Introduction: In basic research, it is essential to use an inducible promoter which can be controlled to express a small amount of protein for studying their roles in the cell. Pspac, a well-known weak promoter for Bacillus subtilis, uses isopropyl β -D-1-thiogalactopyranoside (IPTG) as an inducer. However, plasmids carrying this promoter such as pHCMC05 still have a disadvantage which harbors a repetitive DNA fragment of about 200 bp, resulting in structural instability in Escherichia coli, causing difficulty during cloning. Methods: In this study, we constructed a plasmid that does not carry the repetitive sequences and investigated plasmid structural stability in E. coli, then measured the β -galactosidase reporter gene (bgaB) expression in B. subtilis. Results: The constructed plasmid pHT2002 was stable over 56 generations while pHCMC05-bgaB was structurally instable and ultimately lost after 42 generations. BgaB activities and Western-blot indicated that BgaB-coding gene under control of IPTG-inducible promoter Pspac could be expressed at low levels. Conclusion: The study demonstrated that the new expression plasmid without the repeated sequences retained its structural stability in E. coli facilitating the cloning step. The expression plasmid with Pspac promoter for B. subtilis could be used to express a modest amount of the heterologous protein in the presence of IPTG.
INTRODUCTION
Bacillus subtilis is a Gram-positive bacterium considered as a microbial cell factory. B. subtilis (i) is recognized as GRAS microorganism, which is nonpathogenic and does not produce endotoxin; (ii) capable of secreting directly into culture medium; (iii) has a large amount of well understood genetic information; (iv) its vector expression system has been established 1 . For overexpression of recombinant proteins, the most easy-to-use expression system in B. subtilis is the pHT system, for examples pHT plasmids carrying Pgrac (also called Pgrac01) 2 with the Pgrac100 promoter 3 , delivered by MoBiTec and the Pgrac212 increased the mRNA half-life by three times that of Pgrac 4 . However, in practice, scientists sometimes need vectors for low inducible expression, for example for expression of some proteins for metabolic engineering or some functional membrane proteins. Therefore, it is essential to use an inducible promoter which can be controlled to express a modest amount of proteins for studying their roles in the cell. Pspac promoter is an appropriate option for this purpose, which is a weak promoter, approximately 50 times weaker than the Pgrac promoter 2, 5 .
Current available plasmid carrying Pspac promoter, pHCMC05 consists of a repeated sequence DNA repeat of about 117 bp (TAACT-CACATTAATTGCGTTGCGCTCACTGC-CCGCTTTCCAGTCGGGAAACCTGTCGT-GCCAGCTGCATTAATGAATCGGCCAACGCG C-GGGGAGAGGCGGTTTGCGTATTGGGCGC) 6 . This repeated sequence was detected to be related to the structural instability when amplifying in E. coli, which could promote the homologous recombination causing the alteration of plasmid structure and the deletion of target genes 7 . According to those reasons, we aim to construct E. coli structurally stable plasmid carrying Pspac promoter that could be applied to express a small amount of protein by addition of the inducer in B. subtilis. In this study, we constructed plasmid pHT2002, carrying Pspac promoter and not containing repeated sequence. The structural stability of pHT2002 was investigated along with plasmid pHCMC05-bgaB based on the expression of the β -galactosidase (bgaB) reporter gene in E. coli and restriction map analysis. Also, we checked the presence of BgaB protein by Western-blot and measured the BgaB activities expressed under 
MATERIALS -METHODS

Bacterial strains and growth conditions
endA1 recA1 supE44 thi-1 gyrA96 relA1 tonA panD) (Invitrogen) was used for gene cloning. B. subtilis 1012 (leuA8 metB5 trpC2 hsdRM1) (Mobitec) was used for expression of recombinant plasmids. The bacterial cells were cultured in Luria-Bertani (LB) broth at 37 • C. Antibiotics were added at the appropriate concentration: ampicillin (Fisher BioReagents) at 100 µg/ml, chloramphenicol (Sigma) at 10 µg/ml.
Construction of the expression plasmid
The plasmid pHT2002 was different from pHCMC05-bgaB 8, 9 ( Figure 1A ) at 117 bp repeated sequence, which was removed in pHT2002. To generate the pHT2002 plasmid, we inserted the coding sequence for the Pspac promoter into the backbone plasmid pHT212 8 . Plasmid pHT212 derives from pHCMC05 and contains promoter Pgrac212 and the bgaB gene, which does not have the repeated sequence. The development of plasmid pHT212 from pHCMC05 was described elsewhere 8 . First, the coding sequence of the Pspac gene was amplified by PCR using ON632 (TAGGCGGGCTGCCCCGGGGACG) and ON1249 (CGTTTCCACCGGAATTAGCTTG) (Macrogen) with pHCMC05 as a template. The 370 bp amplified sequence was cleaved with BamHI (Thermo Scientific) and KpnI (Thermo Scientific) and ligated into pHT212 treated with the same enzymes resulting in pHT2002. The structure of the plasmid pHT2002 is shown in Figure 1B .
Investigation of the structural stability of the vector in E. coli
The structural stability of the two plasmids pHCMC05-bgaB and pHT2002 was investigated in E. coli OmniMAX via expression of BgaB on Xgal (5-bromo-4-chloro-3-indolyl-beta-Dgalacto-pyranoside) (Thermo Scientific) plates in the presence of ampicillin (100 μg/ml). A single blue colony of the chosen strain of E. coli, carrying the respective plasmid, was taken from an agar plate inoculated into 10 ml LB-broth with ampicillin (LB-Amp) and incubated 12 hours on an orbital shaker at 37 o C, 250 rpm. The cells were subcultured by transferring 5 μl culture into 10 ml fresh LB-Amp every 12 hours for eight times. At the same time, the cultures were diluted to 10 6 times and spread on LB-Amp-Xgal plates. The appearing of the white colonies on the LB-Amp-Xgal plate indicated that the original plasmid was not in E. coli cells. In parallel, the plasmids from these subcultured were extracted for restriction analysis, allowing for comparisons of DNA fragment sizes at different subcultures.
Expression of the reporter β -galactosidase
Expression of the reporter protein BgaB using pHT2002 under the regulation of Pspac with IPTG inducer was measured in B. subtilis 1012. B. subtilis 1012 strains carrying the recombinant plasmids pHT2002 and pHT1512 (negative) was cultured in an LB medium containing the appropriate antibiotic. We followed the protocol as described elsewhere 10 . Briefly, the bacterial cells were grown to the midlogarithmic growth phase and then induced with 0.1 mM, 1 mM IPTG. The cells were collected before induction (0 hour), after 2 hours and 4 hours of induction in Eppendorf tubes at an OD 600 of 2.4 after centrifugation. Samples were prepared for activity measurements and SDS-PAGE analysis. The BgaB activities were represented by MUG unit because of using MUG substrate and measuring the fluorescence intensity at Ex/Em = 360/460 nm. We used the multi-mode microplate reader Clario Star machine (BMG LABTECH), 384-well black plate with clear flat bottoms to measure the MUG fluorescence signals. All data were averaged from three independent samples of each time point. Mean values are given together with the standard deviations using Excel with the function STDEV.
For Western blot, the cells were lysed by addition of lysozyme, and sample buffer was added to 150 µL and 8 µL each were applied to SDS-PAGE. The protein from SDS-PAGE was transferred to nitrocellulose membrane (Bio-Rad) using a Bio-Rad apparatus. Western-Blot was performed with primary antibodies that were resistant to BgaB developed in mice (raised by the lab), used at a dilution of 1: 2000; and used at a dilution of 1: 10000 for the secondary antibody Anti-Mouse IgG (whole molecule)-Peroxidase antibody (Sigma). The signals from the blot were developed using TMB substrate (Sigma). 
RESULTS
The removal of the 117 bp repeated sequence results in the stable structure of the plasmid carrying Pspac-bgaB promoter in E. coli.
We investigated the structural stability of two plasmids pHCMC05-bgaB and pHT2002 in E. coli for 48 generations after eight subcultures. The cells were cultured/subcultured in the LB-Amp medium and then spread on LB-Amp-Xgal plate. The blue colonies indicated that the plasmid remained stable in the E. coli cells and the white colonies indicated the structural instability. The result showed that all colonies containing pHT2002 after 7 (the 1 st culture), 28 (the 4 th subculture) or 56 (the 8 th subculture) generations exhibited a blue phenotype (Figure 2) , demonstrating its structural stability. According to the results in Figure 2 , white colonies appeared on the plate of pHCMC05-bgaB in the 4 th subculture and completely white in the 8 th subculture. Thus, these plates consisted of E. coli containing plasmid pHCMC05-bgaB, which was altered in structure leading to the loss of bgaB gene sequence due to the homologous recombination between the repeats. At this point, the predicted altered structure of pHCMC05-bgaB was named pHCMC05-bgaB Delta. The homologous recombination at the repeated regions of pHCMC05-bgaB resulting in two plasmids, but only plasmid pHCMC05-bgaB Delta could be selected because of the presence of Ampicillin resistant gene.
To clarify the results of observation of white-blue colonies associated with the structural alteration leading to the loss of the target gene bgaB, we extracted plasmids in the cells from the subcultures. Then we performed the restriction analysis with EcoRV for the plasmids from the 1st culture, 4 th , 6 th , 8 th subculture. By calculation, EcoRV cut the plasmids pHCMC05-bgaB and pHT2002 into 3 fragments (Figures 3 and 4) , while the pHCMC05-bgaB Delta does not have EcoRV site. Figure 3 showed the size of each of the fragments when plasmids were cleaved with this enzyme. All restriction digestions were carried out in two hours at 37 o C. The samples were analyzed by agarose gel electrophoresis of which results were shown in Figure 4 . Figure 4 showed the electrophoresis gel that after being cleaved with EcoRV enzyme, the digest bands of the plasmid from the cells carrying pHCMC05-bgaB started to change from the 6th subculture (after 42 generations). A bright band appeared as about over 3000 bp corresponded to the size of the modified plasmid of pHCMC05-bgaB with no EcoRV restriction site in the plasmid. In the 8th subculture (after 56 generations), only the band with size corresponded to the homologous recombinant structure was found. The results indicated that over 56 generations, pHCMC05-bgaB completely lost the target gene bgaB. On the contrary, pHT2002 cut with EcoRV enzyme showed bands as predicted after the 8th subculture, which proved that this plasmid was structurally stable for at least 56 generations. These results led to the conclusion that plasmid pHT2002 had a stable structure over generations in E. coli.
The induction of plasmid pHT2002 to express BgaB in B. subtilis
For this experiment, we aim to examine the expression levels of target protein BgaB in B. subtilis/pHT2002 under the control of the Pspac promoter by using inducer IPTG. B. subtilis/pHT1512 containing the corresponding expression system but lacking the bgaB gene used as a negative-control strain. The B. subtilis strains were grown in liquid media and the cells were collected for β -galactosidase activity. Figure 5 showed the BgaB activities of these two B. subtilis strains. Compared with B. subtilis /HT1512 strain, B. subtilis /pHT2002 showed the expression of BgaB, which increased in the presence of 0.1 mM and 1 mM IPTG and over incubation time 2 hours, 4 hours. The result indicated that the expression level of B. subtilis/pHT2002 regulated by the Pspac promoter via an IPTG inducer. In comparison with Pgrac promoters using the same assay, the expression levels of BgaB under control of Pspac promoter from pHT2002 was less than 3000 times that of from Pgrac01 10 . The results showed that the heterologous bgaB gene could be induced for the expression at modest levels by the addition of IPTG.
Result of Western blot
Since we could not detect the protein expression via SDS-PAGE because of a low level of protein expression, we used the Western Blot to detect the target BgaB protein. Figure 6 , lane 5 showed a thick band corresponding to BgaB size (78 kDa) for the B. subtilis/pHT2002 sample induced with 1mM IPTG, while there are light bands for the other samples. This result re-confirmed that Pspac is a weak promoter to regulate low levels of protein expression. This result is consistent with the objective of this study.
DISCUSSION
We could show here that the newly constructed plasmid which contained Pspac promoter reached three objectives which are (i) stable in structure, (ii) low protein expression and (iii) controllable by using inducer. It is the first successful step to carry out further researches to test the expression with other reporter proteins. In terms of application, this plasmid is available for protein expression on the surface of the cell such as sortases, which have been used to anchor heterologous proteins on the cell wall of different Grampositive bacterial species. Sortase A, in particular, is a membrane-anchored transpeptidase 11 . The excess of this protein expression will cause membrane congestion 12 . Therefore, it is required to have a low expression system. Another example is PrkC protein kinase, which is responsible for triggering spore germination in response to muropeptides. PrkC exerts its effects through signal transduction pathways involving phosphorylation of its substrates. They need only a small amount, and depending on the stage of the cell they need to be expressed 13 . We are interested in using engineered bacterial expression systems for fundamental researches concerned about studying protein structures and functions in cells, and the finding suggests that this plasmid development is suitable for that purpose.
CONCLUSION
The study demonstrated that the new expression plasmid without the repeated sequences conferred its structural stability in E. coli, which facilitate the cloning step. On the other hand, the expression plasmid with Pspac promoter could be used to express a modest amount of the heterologous protein in the presence of IPTG in B. subtilis. 
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